Saleh S - Search Results

1

Riociguat for pulmonary arterial hypertension associated with congenital heart disease.

Rosenkranz S, Ghofrani HA, Beghetti M, Ivy D, Frey R, Fritsch A, Weimann G, Saleh S, Apitz C. Rosenkranz S, et al. Among authors: saleh s. Heart. 2015 Nov;101(22):1792-9. doi: 10.1136/heartjnl-2015-307832. Epub 2015 Jul 1. Heart. 2015. PMID: 26135803 Free PMC article. Clinical Trial.

2

Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Frey R, Saleh S, Becker C, Mück W. Frey R, et al. Among authors: saleh s. Pulm Circ. 2016 Mar;6(Suppl 1):S58-65. doi: 10.1086/685019. Pulm Circ. 2016. PMID: 27162629 Free PMC article.

3

Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food.

Saleh S, Frey R, Becker C, Unger S, Wensing G, Mück W. Saleh S, et al. Pulm Circ. 2016 Mar;6(Suppl 1):S66-74. doi: 10.1086/685020. Pulm Circ. 2016. PMID: 27162630 Free PMC article.

4

Population pharmacokinetics of single-dose riociguat in patients with renal or hepatic impairment.

Saleh S, Becker C, Frey R, Mück W. Saleh S, et al. Pulm Circ. 2016 Mar;6(Suppl 1):S75-85. doi: 10.1086/685647. Pulm Circ. 2016. PMID: 27162631 Free PMC article.

5

Population pharmacokinetics and the pharmacokinetic/pharmacodynamic relationship of riociguat in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Saleh S, Becker C, Frey R, Mück W. Saleh S, et al. Pulm Circ. 2016 Mar;6(Suppl 1):S86-96. doi: 10.1086/685404. Pulm Circ. 2016. PMID: 27162632 Free PMC article.

6

Pharmacokinetic interaction study between riociguat and the combined oral contraceptives levonorgestrel and ethinylestradiol in healthy postmenopausal women.

Frey R, Unger S, van der Mey D, Becker C, Saleh S, Wensing G, Mück W. Frey R, et al. Among authors: saleh s. Pulm Circ. 2016 Mar;6(Suppl 1):S97-S102. doi: 10.1086/685428. Pulm Circ. 2016. PMID: 27162633 Free PMC article.

7

Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.

Frey R, Becker C, Saleh S, Unger S, van der Mey D, Mück W. Frey R, et al. Among authors: saleh s. Clin Pharmacokinet. 2018 Jun;57(6):647-661. doi: 10.1007/s40262-017-0604-7. Clin Pharmacokinet. 2018. PMID: 29086344 Free PMC article. Review.

8

Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT).

Huntgeburth M, Kießling J, Weimann G, Wilberg V, Saleh S, Hunzelmann N, Rosenkranz S. Huntgeburth M, et al. Among authors: saleh s. Clin Drug Investig. 2018 Nov;38(11):1061-1069. doi: 10.1007/s40261-018-0698-1. Clin Drug Investig. 2018. PMID: 30238433 Clinical Trial.

9

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.

DeJesus E, Saleh S, Cheng S, van der Mey D, Becker C, Frey R, Unger S, Mueck W. DeJesus E, et al. Among authors: saleh s. Pulm Circ. 2019 Apr-Jun;9(2):2045894019848644. doi: 10.1177/2045894019848644. Pulm Circ. 2019. PMID: 30997864 Free PMC article.

10

Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis.

Derichs N, Taylor-Cousar JL, Davies JC, Fajac I, Tullis E, Nazareth D, Downey DG, Rosenbluth D, Malfroot A, Saunders C, Jensen R, Solomon GM, Vermeulen F, Kaiser A, Willmann S, Saleh S, Droebner K, Sandner P, Bear CE, Hoffmann A, Ratjen F, Rowe SM; Rio-CF Study Group. Derichs N, et al. Among authors: saleh s. J Cyst Fibros. 2021 Nov;20(6):1018-1025. doi: 10.1016/j.jcf.2021.07.015. Epub 2021 Aug 19. J Cyst Fibros. 2021. PMID: 34419414 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,249 results

Search Page

Filters